Technology Offerings

Tryptanthrin-Derivatives Show Promise for Acute Lymphocytic Leukemia

The invention offers a novel class of Tryptanthrin-derivatives and a method for preparing the derivatives. These compounds shall be useful as drugs for the treatment of ALL and/or other proliferating diseases.

Further Information: PDF

Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V.
Phone: +49 (0)89/1205-6000

Contact
Dr. Wolfgang Knappe

Comments (0)

Write a comment